Apolipoprotein E polymorphism influences the cerebral metabolic pattern in Alzheimer's disease

Neuroscience Letters

Volumn 254, Issue 1, 1998, Pages 49-52

  Mielke, R ^a   Zerres, K ^b   Uhlhaas, S ^b   Kessler, J ^a   Heiss, W D ^a  

^a MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Alleles; Alzheimer's Disease; Apolipoprotein E; Glucose metabolism; Positron emission tomography

Indexed keywords

APOLIPOPROTEIN E; FLUORODEOXYGLUCOSE F 18;

ALZHEIMER DISEASE; ARTICLE; BRAIN CELL; BRAIN METABOLISM; CLINICAL ARTICLE; DEMENTIA; GENOTYPE; GLUCOSE METABOLISM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

AGE FACTORS; AGE OF ONSET; AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; BASAL GANGLIA; BRAIN STEM; CEREBELLUM; CEREBRAL CORTEX; DEMENTIA; DNA; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; FRONTAL LOBE; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INTELLIGENCE TESTS; LEUKOCYTES; LINEAR MODELS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; TEMPORAL LOBE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032544377     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00673-9     Document Type: Article

References (22)

1. Arnold, S.E., Hyman, T.B., Flory, J., Damasio, A.R. and Van Hoesen, G.W., The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease, Cereb. Cortex, 1 (1991) 103-116.
2. Arriagada, P.V., Growdon, J.H., Hedley-Whyte, E.T. and Hyman, B.T., Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease, Neurology, 42 (1992) 631-639.
3. Corder, E.H., Jelic, V., Basun, H., Lannfelt, L., Valind, S., Winblad, B. and Nordberg, A., No difference in cerebral glucose metabolism in patients with Alzheimer disease and differing apolipoprotein E genotypes, Arch. Neurol., 54 (1997) 273-277.
4. Davignon, J., Gregg, R.E. and Sing, C.F., Apolipoprotein E polymorphism and atherosclerosis, Arteriosclerosis, 8 (1988) 1-21.
5. 18F]2-fluoro-2-deoxy-D-glucose, J. Cereb. Blood Flow Metab., 4 (1984) 212-223.
6. Herholz, K., Adams, R., Kessler, J., Szelies, B., Grond, M. and Heiss, W.D., Accuracy of diagnosis of Alzheimer's disease with positron emission tomography, Dementia, 1 (1990) 156-164.
7. Higuchi, M., Arai, H., Nakagawa, T., Higuchi, S., Muramatsu, T., Matsushita, S., Kosaka, Y., Itoh, M. and Sasaki, H., Regional cerebral glucose utilization is modulated by the dosage of apolipoprotein E type 4 allele and alpha1-antichymotrypsin type A allele in Alzheimer's disease, NeuroReport, 8 (1997) 2639-2643.
8. Ichimiya, A., Herholz, K., Mielke, R., Kessler, J., Slansky, I. and Heiss, W.D., Difference of regional cerebral metabolic pattern between presenile and senile dementia of Alzheimer type: a factor analytic study, J. Neurol. Sci., 123 (1994) 11-17.
9. Kopke, E., Tung, Y.C., Shaikh, S., Alonso, A.C., Iqbal, K. and Grundke-Iqbal, I., Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease, J. Biol. Chem., 268 (1993) 24374-24384.
10. Ma, J., Brewer, H.B. and Potter, H., Alzheimer A beta neurotoxicity: promotion by antichymotrypsin, ApoE4; inhibition by A beta-related peptides, Neurobiol. Aging, 17 (1966) 773-780.
11. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E.M., Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease, Neurology, 19 (1984) 939-944.
12. Mielke, R., Herholz, K., Grond, M., Kessler, J. and Heiss, W.D., Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type, Neurobiol. Aging, 13 (1992) 93-98.
13. Mielke, R., Pietrzyk, U., Jacobs, A., Fink, G.R., Ichimiya, A., Kessler, J., Herholz, K. and Heiss, W.D., HMPAO SPECT and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern, Eur. J. Nucl. Med., 21 (1994) 1052-1060.
14. Mielke, R., Schröder, R., Fink, G., Kessler, J., Herholz, K. and Heiss, W.D., Regional cerebral glucose metabolism and postmortem pathology in Alzheimer's disease, Acta Neuropathol., 91 (1996) 174-179.
15. Ohm, T.G., Kirca, M., Bohl, J., Scharnagl, H., Groß, W. and März, W., ApoE polymorphism influences not only cerebral senile plaques load but also Alzheimer-type neurofibrillary tangle formation, Neurosci., 66 (1995) 583-587.
16. Poirier, J., Delisle, M.C., Quirion, R., Aubert, I., Farlow, M., Lahiri, D., Hui, S., Bertrand, P., Nalbantoglu, J., Gilfix, B.M. and Gauthier, S., Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease, Proc. Natl. Acad. Sci. USA, 92 (1995) 1260-1264.
17. Reiman, E.M., Caselli, R.J., Yun, L.S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S.N. and Osborne, D., Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E, N. Engl. J. Med., 334 (1996) 752-758.
18. Small, G.W., Mazziotta, J.C., Collins, M.T., Baxter, L.R., Phelps, M.E., Mandelkern, M.A., Kaplan, A., La Rue, A., Adamson, C.F. and Chang, L., Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease, J. Am. Med. Assoc, 273 (1995) 942-947.
19. Strittmatter, W.J., Weisgarber, K.H., Goedert, M., Saunders, A.M., Huang, D., Corder, E.H., Dong, L.M., Jakes, R., Alberts, M.J., Gilbert, J.R., Han, S.H., Hulette, C., Einstein, G., Schmechel, D.E., Pericak-Vance, M.A. and Roses, A.D., Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype, Exp. Neurol., 125 (1994) 163-171.
20. Tierney, M.C., Fisher, R.H., Lewis, A.J., Zorzitto, M.L., Snow, W.G., Reid, D.W. and Nieuwstraten, P., The NINCDS-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer's disease, a clinicopathologic study of 57 cases, Neurology, 38 (1988) 359-364.
21. 18F]2-fluoro-deoxy-D-glucose: a critical appraisal of optimization procedures, J. Cereb. Blood Flow Metab., 5 (1985) 115-125.
22. Yasuno, F., Imamura, T., Hirono, N., Ishii, K., Sasaki, M., Ikejiri, Y., Hashimoto, M., Shimomura, T., Yamashita, H. and Mori, E., Age at onset and regional cerebral glucose metabolism in Alzheimer's disease, Dementia Geriatr. Cogn. Dis., 9 (1998) 63-67.